Anti-TNF Therapy Reduces Serum Levels of Chemerin in Rheumatoid Arthritis: A New Mechanism by Which Anti-TNF Might Reduce Inflammation

por Herenius, Marieke M. J., Oliveira, Ana S. F., Wijbrandts, Carla A., Gerlag, Daniëlle M., Tak, Paul P., Lebre, Maria C.
Publicado 2013

The Gene Expression Profile in the Synovium as a Predictor of the Clinical Response to Infliximab Treatment in Rheumatoid Arthritis

por Lindberg, Johan, Wijbrandts, Carla A., van Baarsen, Lisa G., Nader, Gustavo, Klareskog, Lars, Catrina, Anca, Thurlings, Rogier, Vervoordeldonk, Margriet, Lundeberg, Joakim, Tak, Paul P.
Publicado 2010

Regulation of IFN response gene activity during infliximab treatment in rheumatoid arthritis is associated with clinical response to treatment

por van Baarsen, Lisa GM, Wijbrandts, Carla A, Rustenburg, François, Cantaert, Tineke, van der Pouw Kraan, Tineke CTM, Baeten, Dominique L, Dijkmans, Ben AC, Tak, Paul P, Verweij, Cornelis L
Publicado 2010

Monocyte Scintigraphy in Rheumatoid Arthritis: The Dynamics of Monocyte Migration in Immune-Mediated Inflammatory Disease

por Thurlings, Rogier M., Wijbrandts, Carla A., Bennink, Roelof J., Dohmen, Serge E., Voermans, Carlijn, Wouters, Diana, Izmailova, Elena S., Gerlag, Danielle M., van Eck-Smit, Berthe L. F., Tak, Paul P.
Publicado 2009

The Features of the Synovium in Early Rheumatoid Arthritis According to the 2010 ACR/EULAR Classification Criteria

por van de Sande, Marleen G. H., de Hair, Maria J. H., Schuller, Yvonne, van de Sande, Gijs P. M., Wijbrandts, Carla A., Dinant, Huib J., Gerlag, Danielle M., Tak, Paul P.
Publicado 2012

Surprising negative association between IgG1 allotype disparity and anti-adalimumab formation: a cohort study

por Bartelds, Geertje M, de Groot, Els, Nurmohamed, Michael T, Hart, Margreet HL, van Eede, Peter H, Wijbrandts, Carla A, Crusius, Jakob BA, Dijkmans, Ben AC, Tak, Paul Peter, Aarden, Lucien, Wolbink, Gerrit J
Publicado 2010

Selective involvement of ERK and JNK mitogen-activated protein kinases in early rheumatoid arthritis (1987 ACR criteria compared to 2010 ACR/EULAR criteria): a prospective study ai...

por de Launay, Daphne, van de Sande, Marleen GH, de Hair, Maria JH, Grabiec, Aleksander M, van de Sande, Gijs PM, Lehmann, K Aad, Wijbrandts, Carla A, van Baarsen, Lisa GM, Gerlag, Danielle M, Tak, Paul P, Reedquist, Kris A
Publicado 2011

COVID-19 vaccine acceptance over time in patients with immune-mediated inflammatory rheumatic diseases

por Boekel, Laura, Hooijberg, Femke, Besten, Yaëlle R, Vogelzang, Erik H, Steenhuis, Maurice, Leeuw, Maureen, Atiqi, Sadaf, van Vollenhoven, Ronald, Lems, Willem F, Bos, Wouter H, Wijbrandts, Carla A, Gerritsen, Martijn, Krieckaert, Charlotte, Voskuyl, Alexandre E, van der Horst-Bruinsma, Irene E, Tas, Sander W, Boers, Maarten, Rispens, Theo, Nurmohamed, Michael T, Wolbink, Gertjan
Publicado 2022

Antibody development and disease severity of COVID-19 in non-immunised patients with rheumatic immune-mediated inflammatory diseases: data from a prospective cohort study

por Boekel, Laura, Hooijberg, Femke, Vogelzang, Erik H, Besten, Yaëlle R, Leeuw, Maureen, Atiqi, Sadaf, van Vollenhoven, Ronald F, Wijbrandts, Carla A, Gerritsen, Martijn, Krieckaert, C, Dijkshoorn, Bas, Bakhlakh, Siham, Crooijmans, Juliette J, Voskuyl, Alexandre, van der Horst-Bruinsma, Irene E, Lems, Willem, Kuijpers, Taco W, van Ham, S Marieke, Wieske, Luuk, Eftimov, Filip, Kummer, Laura Y, van Dam, PJ Koos, Stalman, Eileen W, Steenhuis, Maurice, Keijzer, Sofie, Cristianawati, Olvi, Keijser, Jim, Loeff, Floris C, Tas, Sander W, Nurmohamed, Michael T, Boers, Maarten, Rispens, Theo, Wolbink, Gertjan
Publicado 2022